跳至主要内容
临床试验/CTRI/2021/04/032963
CTRI/2021/04/032963尚未招募2/3 期

A PROSPECTIVE STUDY TO EVALUATE THE SAFETY ANDEFFICACY OF LEVETIRACETAM IN COMPARISON TOMAGNESIUM SULPHATE IN THE MANAGEMENT OF ECLAMPSIA

Dr Sindhu Manne1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2021年1月5日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
76
试验地点
1
主要终点
TO OBSERVE FOR CONVULSIONS POST ANTIEPILEPTIC TREATMENT DURING THE PERIOD PATIENT IS IN HOSPITAL

研究概览

简要总结

If the drug Levetiracetam can be proven to be as effective as magnesium sulphate and relatively safe in patients than further continued assessment and use of the drug can be done.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • ALL PATIENTS PRESENTING WITH FEATURES OF ECLAMPSIA DURING THE SAID PERIOD WILL BE RECRUITED INTO THE STUDY ALL PATIENTS GIVING INFORMED AND WRITTEN CONSENT FOR INVESTIGATIONS.

排除标准

  • PATIENTS WHO WERE DIAGNOSED WITH OTHER CAUSES OF CONVULSIONS IN PREGNANCY LIKE CEREBRAL MALARIA AND EPILEPSY CHRONIC HYPERTENSIVE PREGNANT FEMALES PREGNANT FEMALES WITH FETAL ANOMALIES DETECTED ON USG.

结局指标

主要结局

TO OBSERVE FOR CONVULSIONS POST ANTIEPILEPTIC TREATMENT DURING THE PERIOD PATIENT IS IN HOSPITAL

时间窗: DURATION OF HOSPITAL STAY (1-2 WEEKS)

次要结局

  • NOT APPLICABLE(NOT APPLICABLE)

研究者

发起方
Dr Sindhu Manne
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

STUDY COMPARISON OF EFFICACY OF LEVETIRACETAM... | 临床试验